Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood
|
May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood Cancer Discovery
|
January 11, 2022
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies
Sisi Zheng, Elisabeth Gillespie, Ammar S Naqvi, et al.
Blood Advances
|
July 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
Armin Ghobadi, Jack H Landmann, Alun Carter, et al.
Cancer Discovery
|
February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
Nathan Singh, Yong Gu Lee, Olga Shestova, et al.
Journal of Translational Medicine
|
July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)
Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Nature Immunology
|
January 16, 2026
BACH2 regulates T cell lineage state to enhance CAR T cell function
Tien-Ching Chang, Amanda Heard, John Lattin, et al.
Cell
|
December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunction
Charly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy response
Riley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Nature Medicine
|
April 23, 2021
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells
Nathan Singh, Noelle V Frey, Boris Engels, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood
|
May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood Cancer Discovery
|
January 11, 2022
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies
Sisi Zheng, Elisabeth Gillespie, Ammar S Naqvi, et al.
Blood Advances
|
July 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
Armin Ghobadi, Jack H Landmann, Alun Carter, et al.
Cancer Discovery
|
February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
Nathan Singh, Yong Gu Lee, Olga Shestova, et al.
Journal of Translational Medicine
|
July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)
Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Nature Immunology
|
January 16, 2026
BACH2 regulates T cell lineage state to enhance CAR T cell function
Tien-Ching Chang, Amanda Heard, John Lattin, et al.
Cell
|
December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunction
Charly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy response
Riley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Nature Medicine
|
April 23, 2021
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells
Nathan Singh, Noelle V Frey, Boris Engels, et al.
Page
of 6